We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.94B
AUM Growth
+$118M
Cap. Flow
+$6.97M
Cap. Flow %
0.36%
Top 10 Hldgs %
37.02%
Holding
344
New
25
Increased
72
Reduced
94
Closed
36

Top Buys

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$26.8M
2
UNH icon
UnitedHealth
UNH
+$15.1M
3
EW icon
Edwards Lifesciences
EW
+$10.5M
4
MSFT icon
Microsoft
MSFT
+$10.2M
5
BABA icon
Alibaba
BABA
+$9M

Top Sells

Rank Stock Value
1
GD icon
General Dynamics
GD
+$26.2M
2
NUE icon
Nucor
NUE
+$26M
3
MMM icon
3M
MMM
+$24.3M
4
T icon
AT&T
T
+$18.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Communication Services 16.56%
2 Industrials 15.39%
3 Consumer Discretionary 13.53%
4 Technology 12.83%
5 Healthcare 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
126
Applied Materials
AMAT
$398B
$596K 0.03%
+12,905
New +$665K
CHDN icon
127
Churchill Downs
CHDN
$5.76B
$593K 0.03%
12,000
-6,600
-35% -$309K
HMC icon
128
Honda
HMC
$39.9B
$585K 0.03%
20,000
SKM icon
129
SK Telecom
SKM
$12.2B
$583K 0.03%
15,175
IVV icon
130
iShares Core S&P 500 ETF
IVV
$872B
$580K 0.03%
2,125
+70
+3% +$19K
ABEV icon
131
Ambev
ABEV
$48.2B
$579K 0.03%
125,000
-232
-0.2% -$1.36K
SAP icon
132
SAP
SAP
$209B
$578K 0.03%
5,000
-13
-0.3% -$1.47K
VALE icon
133
Vale
VALE
$63.8B
$577K 0.03%
45,005
-5,095
-10% -$69.6K
PFE icon
134
Pfizer
PFE
$142B
$572K 0.03%
16,623
-1,354
-8% -$46.3K
MUFG icon
135
Mitsubishi UFJ Financial
MUFG
$254B
$565K 0.03%
100,000
THO icon
136
Thor Industries
THO
$3.95B
$565K 0.03%
5,800
-9,575
-62% -$977K
RIO icon
137
Rio Tinto
RIO
$158B
$555K 0.03%
10,000
SM icon
138
SM Energy
SM
$7.58B
$555K 0.03%
21,600
-500
-2% -$11.7K
MTB icon
139
M&T Bank
MTB
$35.8B
$553K 0.03%
3,250
-3,125
-49% -$560K
HBAN icon
140
Huntington Bancshares
HBAN
$34.5B
$549K 0.03%
37,200
+5,500
+17% +$82.7K
PLNT icon
141
Planet Fitness
PLNT
$4.43B
$549K 0.03%
12,500
SDS icon
142
ProShares UltraShort S&P500
SDS
$420M
$546K 0.03%
571
+250
+78% +$243K
AZN icon
143
AstraZeneca
AZN
$266B
$545K 0.03%
7,763
+100
+1% +$7.19K
TSG
144
DELISTED
The Stars Group Inc.
TSG
$545K 0.03%
15,000
+3,500
+30% +$117K
CNQ icon
145
Canadian Natural Resources
CNQ
$98.6B
$541K 0.03%
30,630
-7,223
-19% -$122K
SAN icon
146
Banco Santander
SAN
$202B
$534K 0.03%
104,348
FTNT icon
147
Fortinet
FTNT
$113B
$531K 0.03%
42,500
-80
-0.2% -$947
DD icon
148
DuPont de Nemours
DD
$18.7B
$530K 0.03%
3,173
+79
+3% +$13.2K
TBT icon
149
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
$530K 0.03%
14,750
+3,000
+26% +$112K
BLDP
150
Ballard Power Systems
BLDP
$841M
$529K 0.03%
185,500
-50,500
-21% -$159K

Similar funds

R.H. Bluestein & Co's Q2 2018 Portfolio in Review

As of Q2 2018, R.H. Bluestein & Co held 344 positions worth $1.94B, up 6.5% from $1.82B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

R.H. Bluestein & Co's Q2 2018 filing shows 25 new, 72 increased, 94 reduced and 36 closed positions. Its largest new stake was Spotify: 167,552 shares worth $28.2M. The largest sale was General Dynamics, an estimated $26.2M.

By sector, the portfolio is most concentrated in Communication Services at 17% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • R.H. Bluestein & Co's largest Q2 2018 buy was Spotify: 167,552 shares worth $28.2M.
  • R.H. Bluestein & Co added most to UnitedHealth in Q2 2018, an estimated $15.1M increase.
  • R.H. Bluestein & Co's biggest Q2 2018 reduction was General Dynamics, cutting an estimated $26.2M.
  • R.H. Bluestein & Co fully exited 3M in Q2 2018, selling an estimated $24.3M.
  • R.H. Bluestein & Co's ten largest holdings make up 37% of its $1.94B portfolio in Q2 2018.
  • R.H. Bluestein & Co opened 25 new positions and closed 36 in Q2 2018.
  • R.H. Bluestein & Co's portfolio value rose 6.5% quarter-over-quarter to $1.94B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2018, filed 10 Aug 2018.